Molecule Details
| InChIKey | VGIYMYGMVXPMKV-GWDMYEQXSA-N |
|---|---|
| Compound Name | Piperazine, 1-(((2S)-2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-4-(3-(methoxy-11C-methyl)-2-pyridinyl)- |
| Canonical SMILES | [11CH3]OCc1cccnc1N1CCN(C[C@H]2COc3ccccc3O2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.67 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB15324 |
|---|---|
| Drug Name | ORM-13070 C-11 |
| CAS Number | 1227170-74-2 |
| Groups | investigational |
| ATC Codes | nan |
| Description | ORM-13070 C-11 is under investigation in clinical trial NCT00735774 (Suitability of 11C-ORM-13070 as a PET Tracer). |
Categories: Carbon Radioisotopes
Cross-references: ChemSpider: 52085734